1. Introduction
===============

Porcine pleuropneumonia (PP) is a highly contagious respiratory disease that causes great economic losses worldwide \[[@b1-ijms-14-10626]\]. The disease, which occurs in swine of all ages, is highly infectious, often fatal, and characterized by necrotizing, hemorrhagic bronchopneumonia and serofibrinous pleuritis \[[@b1-ijms-14-10626]\]. *Actinobacillus pleuropneumoniae* (APP) is the causative agent of PP and can spread quickly by air-borne particles and/or touching a contaminated surface, and often kills infected animals in the acute phase when extensive lung hemorrhage and necrosis occur. Swine that survive often develop pleurisy, the sequelaes of local necrosis of the pleura, or became healthy carriers of APP.

The porcing lung infected with APP has previously been reported to result in local production of proinflammatory proteins or to mRNA encoding the cytokines interleukin (IL)-1α, IL-1α, IL-6 and the chemokine IL-8 \[[@b2-ijms-14-10626]\]. Likewise, bioactive protein and/or mRNA code IL10, IL12p35, TNF-α and INF-α have shown to be up-regulated after infection with APP *in vivo* or *in vitro* \[[@b2-ijms-14-10626]--[@b4-ijms-14-10626]\]. Using cDNA microarrays, Moser and co-workers found 307 anonymous transcripts in blood leukocytes from swine that were significantly affected by experimental infection with APP \[[@b5-ijms-14-10626]\]. Hedegaard *et al.* investigated the molecular characterization of the early response in pigs to experimental infection with APP serotype 5B, using cDNA microarrays \[[@b6-ijms-14-10626]\]. In this study, two-colour microarray analysis was conducted to identify genes being significantly differently expressed in non-inflamed lung tissue compared with inflamed lung tissue sampled from the same animal \[[@b6-ijms-14-10626]\]. The samples of lung tissue were studied by manual hybridization to the pig array DIAS_PIG_27K2 that contains 5375 PCR products amplified from unique cDNA clones \[[@b6-ijms-14-10626]\]. Hedegaard and co-workers found three subsets of genes consistently expressed at different levels depending upon the infection status, and a total of 357 genes differed significantly in their expression levels between infected and non-infected lung tissue from infected *versus* non-infected animals \[[@b6-ijms-14-10626]\]. Mortensen *et al.* studied the local transcriptional response in different locations of lung from pigs experimentally infected with the respiratory pathogen APP 5B, using porcine cDNA microarrays (DJF Pig 55 K v1) representing approximately 20,000 porcine genes printed in duplicate \[[@b7-ijms-14-10626]\]. Within the lung, Mortensen and co-workers found a clear division of induced genes as, in unaffected areas a large part of differently expressed genes were involved in systemic reaction to infections, while differently expressed genes in necrotic areas were mainly concerned with homeostasis regulation \[[@b7-ijms-14-10626]\]. However, a limited number of genes relative to the whole Porcine Genome have been studied in previous documents by using cDNA microarrays \[[@b5-ijms-14-10626]--[@b7-ijms-14-10626]\]. Thus, transcriptional profiling of whole porcine genome in lung tissue sampled from inoculated *versus* non-inoculated swine would lead to greater knowledge of the host response dynamics to bacterial infection in the lung. This knowledge is important to obtain a more complete picture of the lung-specific host reactions in the pathogenesis of respiratory infection.

In the present study, the Agilent Whole Porcine Genome Oligo (4 × 44 K) Microarrays (one-color platform), which is a commercially available Agilent Porcine Genechip that included 43,603 probe sets, were used to detect the changes in gene expression of infected pigs' lungs from non-inoculated animals. Ten transcripts (top six up-regulated and top four down-regulated in microarray data) were selected to verify the accuracy and reproducibility of the microarray data by real-time qRT-PCR.

2. Results
==========

2.1. Clinical Symptoms and Necropsy Findings
--------------------------------------------

The symptoms of lung lesions in the TG were typical after swine infected with APP. Swine showed hyperthermia (40.6--42.0 °C), dyspnea and anorexia after inoculation with APP 24--48 h. Two swine died with respiratory distress at post-inoculation 36--48 h. In the autopsy, the lungs were found to be severely damaged by acute, multifocal, fibrino-necrotizing and hemorrhagic pneumonia complicated by acute diffuse fibrinous pleuritis. The tracheobronchial lymphoid nodes were enlarged and congested.

No lesions were observed in CG lung ([Figures 1A](#f1-ijms-14-10626){ref-type="fig"} and [2](#f2-ijms-14-10626){ref-type="fig"}). Lung showed swelling, bleeding and fibrinous exudate sticking to the lung surface in TG ([Figure 1B](#f1-ijms-14-10626){ref-type="fig"}). The histopathologic changes were characterized by hemorrhage, lymphocyte infiltration, fibrinous exudation vascular thrombosis, necrotic focus and edema in TG ([Figure 3](#f3-ijms-14-10626){ref-type="fig"}).

2.2. Microarray Profiling
-------------------------

Expression profiling was conducted using a commercially available Agilent Porcine Genechip that included 43,603 probe sets. The transcriptome of the lung was determined. Expression was detected for 30,574 probes (70.12% of all probe sets) of the CG. A total of 31,957 probes (73.29% of all probe sets) were expressed in TG. When probe set intensities were normalized and filtered, there were still 26353 probes used to significantly identify DE genes. There were 11,929 genes identified as DE at the *p* ≤ 0.01 level by comparing the log2 (normalized signal) of the two groups using T-test analysis.

Hierarchical clustering was applied to the mean log-ratio of the replicated spots from the DE genes by the average linkage and using euclidean distance as the similarity metric ([Figure 4](#f4-ijms-14-10626){ref-type="fig"}). The expression profiles of samples were divided into two groups---one from the non-inoculated swine (M-P-1, M-P-2, M-P-3) and the other group from the inoculated swine (M-P-4, M-P-5, M-P-6).

The principal component map to three-dimensional space, also found that the distance of CG (samples M-P-1, M-P-2, M-P-3) is short, and the gene expression pattern is more consistent. Also the distance of TG (samples M-P-4, M-P-5, M-P-6) is relatively discrete because of the differences in the degree of lesion, and the gene expression pattern is similar ([Figure 5](#f5-ijms-14-10626){ref-type="fig"}).

The six samples were set as variables, the principal component analysis (PCA) of the co-expressed differentially genes (CG *vs* TG) showed the contribution rate of the first principal component which reached 96.95%, the first three principal components of the total contribution rate reach 99.754% ([Table 1](#t1-ijms-14-10626){ref-type="table"}).

2.3. DE Genes Profiling
-----------------------

Of the 11,929 DE genes, 1188 were annotated as swine genes in the GenBank Database (DB). GO and KEGG pathway analyses of the 1188 DE gene lists were conducted using DAVID. There were 89 biological process (BP) categories ([Table 2](#t2-ijms-14-10626){ref-type="table"}), 82 cellular components ([Table 3](#t3-ijms-14-10626){ref-type="table"}), and 182 molecular functions ([Table 4](#t4-ijms-14-10626){ref-type="table"}) were significantly affected by infection with APP (*p* = 0). The BP of the test for over-representation of specific GO terms among the affected genes related to the immune responses were at least 27 ([Table 5](#t5-ijms-14-10626){ref-type="table"}). Furthermore, a number of BP related to metabolism were also identified.

A total of 513 genes were analyzed using gene set enrichment analysis (GSEA). Three hundred and thirty (64.3%) database genes correlated with TG, while the other 183 (35.7%) genes correlated with CG. One hundred and thirty pathways remained for further analysis after size filtering (2 ≤ sizes ≤ 20). Altogether, 102 pathways ([Table 6](#t6-ijms-14-10626){ref-type="table"}) were enriched and up-regulated in the TG and down-regulated in the CG. One pathway (SSC04664) was significantly enriched at a false discovery rate \<25%. Eight pathways (*i.e.*, SSC04664, SSC04930, SSC04914, SSC00140, SSC04621, SSC05221, SSC05218 and SSC03040) were significantly enriched at nominal *p* values of less than 1% and 5%.

Twenty-eight pathways ([Table 7](#t7-ijms-14-10626){ref-type="table"}) were down-regulated in the TG but upregulated in the CG. Six pathways (*i.e.*, SSC05320, SSC04940, SSC05330, SSC04530, SSC04260 and SSC05412) were significant at a false discovery rate of \<25%. Five pathways (*i.e.*, SSC05320, SSC04940, SSC05330, SSC04530 and SSC04260) were significantly enriched at a nominal p value of less than 1% and 5%.

Further analysis revealed that several immune response genes were induced by leading edge analysis for the 13 significant pathways ([Figure 6](#f6-ijms-14-10626){ref-type="fig"}). The genes included those encoding CCL2, GM-CSF, HLA-B associated transcript 1, IGF-1, IL-6, IL-8, IL-18, TNF, Hsp70s, Hsp70.2, Fc fragment of IgE, MAP2K1, PIK3R5, MAPK 14, STAT3 and STAT5B, among others. Many genes related with metabolism as well as ribosomal protein genes were also induced in the inflamed lung. These genes included adiponectin, the Saccharomyces pombe cell division cycle 25 homolog C, cytochrome P450 (3A29, 3A39 and 3A46), FYN oncogene related to SRC, FGR and YES (FYN), the phosphatase and tensin homolog PTEN, PDK, Snrpa, Syk, SPI1, and v-Ha-ras, c-Myc, avian, among others.

The repressed genes comprised those encoding members of the MHC, including (SLA- 2, SLA-3, SLA-6, SLA-8, SLA-DRA, SLA-DQA1, SLA-DRB1, SLA-DMB, SLA-DQA, SLA-DMA, SLA-DQB1), CD40 molecule, CD40, IL-12B, IL-2, myosin, MYH, MYH2, CACNB4, CACNA2D, CPE, and FXYD2, among others.

Genes were frequently induced in the TG included p101, MAP2K1, H-RAS, TNF, MAPK14 and IGF1, while the genes such as CD40, IL12B, IL-2, SLA-2, SLA-3, SLA-6, SLA-8, SLA-DRA, LA-DQA1, SLA-DRB1, SLA-DMB, SLA-DQA, SLA-DMA and SLA-DQB1 were frequently suppressed.

2.4. Verification of Gene Expression Pattern from Microarray Data Using Real-Time QRT-PCR
-----------------------------------------------------------------------------------------

Ten genes (*i.e.*, RETN, ADAM17, GPNMB, CHRM1, ALDH2, IL6, KLRK1, DUOX2, OAS2 and KCNAB1) were selected to confirm expression patterns using real-time qRT-PCR. The results indicate that the expression patterns of all the genes were consistent with the microarray data (*r* = 0.905 ± 0.125, [Figure 7](#f7-ijms-14-10626){ref-type="fig"}).

3. Discussion
=============

In the present study, we revealed 11,929 DE genes using Agilent Whole Porcine Genome Oligo Microarrays (one-color platform) that contain 43,603 probes. There were 1188 genes annotated as swine genes in the GenBank Data Base (DB). GO term analysis identified that a total of 89 BP categories, 82 cellular components and 182 molecular functions were significantly affected and at least 27 BP categories were related to the host immune response.

The NOD-like receptor signaling pathway, Fc epsilon RI signaling pathway, acute myeloid leukemia, melanoma, progesterone-mediated oocyte maturation, spliceosome, type II diabetes mellitus and steroid hormone biosynthesis *etc.* were significantly enriched in inflamed lung. Five pathways as type I diabetes mellitus, autoimmune thyroid disease, allograft rejection, tight junction and cardiac muscle contraction were significantly enriched in non-inflamed lung. The NOD-like receptor signaling pathway is one of the most important pathways associated with microbial recognition and host defense \[[@b8-ijms-14-10626],[@b9-ijms-14-10626]\]. The innate immune system comprises several classes of pattern recognition receptors, including Toll-like receptors (TLRs), NOD-like receptors (NLRs) and RIG-1-like receptors. Two NLRs, NOD1 and NOD2, sense the cytosolic presence of the peptidoglycan fragments, meso-DAP and muramyl dipeptide, respectively, and drive the activation of MAPK and the transcription factor NF-kappaB (NF-κB). A different set of NLRs induces caspase-1 activation through the assembly of large protein complexes named inflammasomes \[[@b9-ijms-14-10626]\]. Inflammasomes are critical for generating mature proinflammatory cytokines in concert with Toll-like receptor signaling pathways \[[@b10-ijms-14-10626]\]. Nod proteins fight off bacterial infections by stimulating proinflammatory signaling and cytokine networks and by inducing antimicrobial effectors, such as nitric oxide and antimicrobial peptides \[[@b11-ijms-14-10626]\]. Fc epsilon RI-mediated signaling pathways in mast cells are initiated by the interaction of antigen with IgE bound to the extracellular domain of the alpha chain of the Fc epsilon RI \[[@b12-ijms-14-10626]--[@b16-ijms-14-10626]\]. The activation pathways are regulated by mast cells that release histamines and proteoglycans (especially heparin), lipid mediators such as leukotrienes (LTC4, LTD4 and LTE4) and prostaglandins (especially PDG2), and cytokines such as TNF-alpha, IL-4 and IL-5. These mediators and cytokines contribute to inflammatory response \[[@b14-ijms-14-10626]\].

The pathways activated in infected lung tissues also include the acute myeloid leukemia pathway characterized by uncontrolled proliferation of clonal neoplastic cells and accumulation in the bone marrow of blasts with an impaired differentiation program \[[@b17-ijms-14-10626]--[@b22-ijms-14-10626]\], progesterone-mediated oocyte maturation pathway involved in endocrine system either insulin/IGF-1 or the steroid hormone progesterone regulation \[[@b23-ijms-14-10626]--[@b25-ijms-14-10626]\], steroid hormone biosynthesis pathway involved in lipid metabolism \[[@b26-ijms-14-10626]--[@b29-ijms-14-10626]\], type II diabetes mellitus involved in endocrine and metabolic diseases \[[@b30-ijms-14-10626]--[@b33-ijms-14-10626]\], spliceosome pathway involved in genetic information processing and transcription \[[@b34-ijms-14-10626]--[@b36-ijms-14-10626]\], and melanoma pathway involved in cancer arising from the malignant transformation of melanocytes \[[@b37-ijms-14-10626]--[@b40-ijms-14-10626]\].

The NOD-like receptor signaling pathway, Fc epsilon RI signaling pathway, acute myeloid leukemia pathway, progesterone-mediated oocyte maturation pathway were strongly linked to the MAPK signaling pathway, which are involved in environmental information processing and signal transduction \[[@b41-ijms-14-10626]--[@b43-ijms-14-10626]\]; the acute myeloid leukemia pathway progesterone-mediated oocyte maturation pathway, melanoma pathway were all strongly linked to the cell cycle pathway, which plays an important role in the regulation of cell growth and death \[[@b44-ijms-14-10626]--[@b46-ijms-14-10626]\]; and the NOD-like receptor signaling pathway, acute myeloid leukemia pathway, type II diabetes mellitus pathway, melanoma pathway were all directly or indirectly linked to the apoptosis pathway, which plays an important role in the regulation of apoptosis (programmed cell death) \[[@b47-ijms-14-10626]--[@b49-ijms-14-10626]\]. Hence, the pathways linked to the cell function regulation, including the MAPK signaling pathway, apoptosis and Cell cycle pathway, were also affected directly or indirectly by the process of the body's resistance to infection.

Many cytokines as shown by leading edge analysis were activated at the site of inflammation, including IL-6, IL-8, IL-18, TNF, GM-CSF, CCL2, p101 protein, HLA-B associated transcript 1, Fc fragment of IgE, MAPK14, MAP2K1, IGF-1, STAT3 and STAT5B, *etc.* IL-6 is responsible for stimulating acute phase protein synthesis, as well as the production of neutrophils in the bone marrow. IL-8 is synthesized by macrophages, endothelial cells and epithelial cells as host defenses against severe infection \[[@b50-ijms-14-10626],[@b51-ijms-14-10626]\]. It serves as a chemical signal that attracts neutrophils to the site of any inflammation. Significant increases in IL-8 and IL6- mRNA after infection with APP have previously been observed in lung lavage as well as lung tissue using northern blotting and *in situ* hybridization \[[@b52-ijms-14-10626],[@b53-ijms-14-10626]\]. IL-18 plays multiple roles in chronic inflammation and in a number of infections and enhances both Th-1- and Th-2-mediated immune response \[[@b54-ijms-14-10626]\]. IL-18 is able to induce IFN gamma, GM-CSF, TNF-α and IL-1 in immunocompetent cells to activate killing by lymphocytes and to up-regulate the expression of certain chemokine receptors. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exit the circulation and migrate into tissues, whereupon they mature into macrophages. Thus, these cells play a part in the immune-inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their number, a process crucial for fighting infection. CCL2 recruits monocytes, memory T cells and dendritic cells to the sites of tissue injury, infection, and inflammation \[[@b55-ijms-14-10626],[@b56-ijms-14-10626]\]. TNF-α can promote inflammatory response by inducing the production of other proinflammatory cytokines at the vicinity of the infection \[[@b57-ijms-14-10626]\], and increase the expression of endothelial surface HLA-B by activation of the nuclear transcription factor NF-κB \[[@b58-ijms-14-10626],[@b59-ijms-14-10626]\]. P101 protein is a single regulatory subunit of the phosphoinositide 3-kinase gamma (PI3Kα), which plays a crucial role in inflammatory and allergic processes \[[@b60-ijms-14-10626],[@b61-ijms-14-10626]\], including neutrophil chemotaxis, mast cell degranulation, and cardiac function \[[@b62-ijms-14-10626],[@b63-ijms-14-10626]\].

Genes involved in a variety of cellular function, including proliferation, differentiation, growth arrest or apoptosis of normal cells were affected including those encoding HLA-B associated transcript 1 \[[@b64-ijms-14-10626],[@b65-ijms-14-10626]\], Fc fragment of IgE \[[@b66-ijms-14-10626],[@b67-ijms-14-10626]\], MAPK14 \[[@b68-ijms-14-10626]\], MAP2K1 \[[@b69-ijms-14-10626]\], H-ras \[[@b70-ijms-14-10626],[@b71-ijms-14-10626]\], IGF-1 \[[@b72-ijms-14-10626]\], STAT3 and STAT5B \[[@b73-ijms-14-10626]\]. Activations of all these genes can stimulate stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes, and also induce neutrophils and macrophages to phagocytose bacterial and foreign antigens.

Immunomodulatory cytokines were significantly suppressed at the site of inflammation. In this study, genes encoding IL2, IL12B, CD40, members of the MHC (SLA-2, SLA-3, SLA-6, SLA-8, SLA-DRB1, SLA-DMB, SLA-DQA, SLA-DMA and SLA-DQB1), as well as SLA-DRA and SLA-DQA1 in a previous study \[[@b74-ijms-14-10626]\], were significantly down-regulated at the site of inflammation.

IL-2 is a type of cytokine immune system signaling molecule which is a leukocytotrophic hormone made in response to microbial infection that can identify the difference between self and non-self \[[@b75-ijms-14-10626],[@b76-ijms-14-10626]\]. When environmental substances (molecules or microbes) gain access to the body, these substances (termed antigens) are recognized as foreign by antigen receptors that are expressed on the surface of lymphocytes. MHC can present antigenic peptides to T lymphocytes, which are responsible for a specific immune response that can destroy the pathogen producing those antigens \[[@b77-ijms-14-10626]\]. CD40 is a co-stimulatory protein found on antigen presenting cells (APC) and is essential in mediating a broad variety of immune and inflammatory responses including T cell-dependent immunoglobulin class switching, memory B cell development, and germinal center formation \[[@b78-ijms-14-10626]\]. The macrophage can express more CD40 and TNF receptors on its surface, which can increase the level of activation culminating in the induction of potent microbicidal substances in the macrophage; these include reactive oxygen species and nitric oxide, leading to the destruction of the ingested microbe \[[@b79-ijms-14-10626]--[@b82-ijms-14-10626]\]. IL-12 is an essential inducer of Th1 cell development, and has an important role in sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection against an intracellular pathogen \[[@b83-ijms-14-10626]\]. The suppression of these immunomodulatory cytokines leads to a decrease in antigenic peptides presented to T lymphocytes by APC via the MHC, as well as to alleviate immune response injury induced by infection at the site of inflammation.

Many genes encoding metabolism as well as ribosomal proteins were affected at the site of inflammation. Genes related to metabolism and ribosomal proteins synthesis were induced in the inflamed lung, including adiponectin, cell division cycle 25 homolog C, cytochrome P450 (CYP 3A29, CYP 3A39 and CYP 3A46), FYN, PTEN, PDK, Snrpa, Syk and SPI1, among others. The repressed genes comprised those encoding MYH1, MYH2, tropomyosin (alpha, beta), troponin I type 3 (cardiac), CACNB4, CACNA2D1, CPE and FXYD2; while the CYP2E1 and the CYP3A29 were known to be down-regulated during inflammation in another study \[[@b84-ijms-14-10626]\].

SOCS3 and CISH, both found to be up-regulated in the present study, are members of the suppressor of cytokine signaling (SOCS) family of proteins whose members regulate protein turnover by targeting proteins for degradation \[[@b42-ijms-14-10626]\]. Expression of the members of the SOCS family is induced by cytokines such as IL-6 and IL-10, both found to be up-regulated in this study; both function as negative feed- back regulators of cytokine signaling \[[@b85-ijms-14-10626],[@b86-ijms-14-10626]\]. The statistically significant increase in mRNA coding for the anti-inflammatory cytokine IL-10, found in inflamed areas of the lung, is probably due to the function of IL-10 in counteracting the host mediated tissue damage caused by proinflammatory and chemotactic cytokines \[[@b87-ijms-14-10626]\]. The lower expression levels observed for genes encoding ribosomal proteins could be due to a general downregulation of ribosomal biogenesis in the necrotic areas of the lung. Previous studies have shown that 41 out of 54 genes encoding ribosomal proteins were down-regulated in Pseudomonas aeruginosa after treatment with H~2~O~2~ induced oxidative stress \[[@b88-ijms-14-10626]\].

As described above, we found that: (1) A total of 89 biological process categories, 82 cellular components and 182 molecular functions were significantly affected, and more than 27 biological process were involved in the host immune response; (2) At the site of inflammation, 13 pathways associated with host responses were affected significantly; many proinflammatory-inflammatory cytokines were activated and several immunomodulatory cytokines were suppressed at the gene expression level reflecting the complex machinery at work during an infection; (3) Many genes which were involved in a variety of cellular functions-proliferation, differentiation, growth arrest or apoptosis of normal cells that activated, could stimulate stem cells to produce granulocyte (neutrophil, eosinophil, and basophil) and monocyte. All changes of the genes and pathways which induced or repressed expression, not only led to decrease in antigenic peptides presented to T lymphocytes by APC via the MHC and alleviated immune response injury induced by infection, but also stimulated stem cells to produce granulocyte (neutrophil, eosinophil, and basophil ) and monocyte, and promote neutrophil and macrophages to phagocytose bacterial and foreign antigen at the site of inflammation. Additional work including more animals and time points is clearly needed to further delineate the host response to APP infection and will contribute to a more detailed description of the dynamics of host responses in general.

4. Experimental Section
=======================

4.1. Animals, Bacterial Inoculation and Samples
-----------------------------------------------

All animal procedures were performed according to protocols approved by the Biological Studies Animal Care and Use Committee of Sichuan Province, China. Twenty 12-week-old male castrated Danish Landrace/Yorkshire/Duroc crossbred swine from a healthy herd free from APP were divided equally into a control group (CG) and the treatment group (TG). APP serotype I (Strain provided by the Animal Biotechnology Center, Laboratory of Animal Disease and Human Health, Sichuan Agricultural University) was cultivated overnight at 37 °C in air on trypticase soy broth (TSB) (Hangwei, Hangzhou, China). Bacterial counts of the suspensions were performed at the same time as the start of the inoculation. The inoculation was performed by holding the pigs (1--10) from the TG in an upright sitting position and spraying 0.25mL diluent containing (3.5--4) × 10^7^ CFU/mL APP per kilogram weight into the nostrils during inspiration. Swine from the CG (swines 11--20) were inoculated with physiological saline (0.9% *wt*/*vol* NaCl) by the same means. In the TG, lung tissue was collected from three swine (swines 1, 2 and 3) after abattage and used for total RNA extraction and pathological analysis. Another three swine (swines 11, 12 and 13) from the CG were sacrificed 48 h post-inoculation and their lung tissues were collected. The remaining swine were used for other trials.

4.2. Microarray Hybridizations and Data Analysis
------------------------------------------------

Total RNA was extracted from tissues using Trizol reagent (Invitrogen, Carlsbad, CA, USA). RNA was purified and DNase treated using the RNeasy QIAGEN RNeasy^®^ Mini Kit. cDNA was synthesized from 2 μg of total-RNA using the direct cDNA Labeling System. Aminoallyl-cRNA was synthesized from cDNA using the Superscript Indirect cDNA Labeling System. The cRNA was purified and DNase treated using RNeasy QIAGEN RNeasy^®^ Mini Kit. RNA integrity was confirmed with a bioanalyzer (model 2100; Agilent Technologies, Palo Alto, CA, USA) according to the manufacturer's protocol. Labeling and hybridization of the cRNA was performed with Agilent Whole Porcine Genome Oligo (4 × 44 K) Microarrays (one-color platform) at the National Engineering Center for Biochip at Shanghai, according to the manufacturer's protocols. The slides were scanned and analyzed using the histogram method with default settings in an Agilent G2565AA and Agilent G2565BA Microarray Scanner System with SureScan Technology. The array data were submitted to GEO \[[@b89-ijms-14-10626]\].

Comparisons between the CG and TG were carried out using three biological replicates for each group. CG samples and TG samples were used for microarray analysis. The six Microarray data were normalized using the quantile normalization method \[[@b90-ijms-14-10626]\] with WebarrayDB (<http://www.webarraydb.org/webarray/>) \[[@b91-ijms-14-10626]\] and were filtered and assessed by the MIDAW online analysis program (<http://www.webarraydb.org/webarray/>) \[[@b92-ijms-14-10626]\] using the method of weighted K-nearest neighbor \[[@b93-ijms-14-10626]\]. *T*-tests and hierarchical cluster analyses of the significantly differentially expressed (DE) genes (clustering method: complete linkage; similarity measure: Pearson product momentum correlation; ordering function: average value) for microarray data were carried out by a MultiExperiment Viewer (MeV) software package (Version 4.5, Dana-Farber Cancer Institute, Boston, MA, USA, 2009) \[[@b94-ijms-14-10626]\].

Tests for statistical significance (*p* \< 0.05), overrepresentation of Gene ontology (GO) terms \[[@b74-ijms-14-10626],[@b95-ijms-14-10626]\], and pathway in Kyoto Encyclopedia of Genes and Genomes (KEGG) DB \[[@b10-ijms-14-10626],[@b96-ijms-14-10626]\] (<http://www.genome.jp/kegg/>) both induced and repressed genes were conducted using the ErmineJ \[[@b97-ijms-14-10626]\] and the Database for Annotation, Visualization and Integrated Discovery (DAVID) Online platform (<http://david.abcc.ncifcrf.gov/>) with a threshold of a minimum three genes annotated at each node. The leading edge analysis for the pathway of differential expression in microarray data with a threshold of a minimum of two genes and maximum of 20 genes annotated at each node was conducted using the GSEA V2.06 package \[[@b98-ijms-14-10626],[@b99-ijms-14-10626]\]. More detailed descriptions of the microarray experiments are available at the NCBI Gene Expression Omnibus \[[@b100-ijms-14-10626]--[@b102-ijms-14-10626]\].

4.3. Real-Time QRT-PCR
----------------------

In order to confirm the reliability the expression profile in the microarray analyses, the expression level 10 gene (six up-regulated and four down-regulated) were performed by real-time qRT-PCR. Sequences for primers were obtained from Genbank and NCBI. Primers were designed using Primer 5 and synthesized at Invitrogen (Shanghai, China) ([Table 1](#t1-ijms-14-10626){ref-type="table"}). Extracted RNA was converted into cDNA by reverse transcription of 1 μL total RNA using SYBR® PrimeScriptTM RT-PCR Kit (TaKaRa, Japan) according to the manufacturer's protocol and then cDNA was stored at −20 °C until use. Quantitative PCR was performed in a 25 μL reaction volume (2 μL cDNA, 12.5 μL of SYBR^®^ Premix Ex TaqTM (2×) TaKaRa, Japan), 0.5 μL of 10 μM upstream and downstream primers respectively, and added ddH~2~O to 25 μL) on the BIO-RAD IQ5 System (BIO-RAD, Hercules, CA, USA). Real-time PCR conditions were as follows: 30 s at 95.0 °C, 40 cycles of denaturation at 95 °C for 5 s followed by 30 s annealing and elongation at 51.2--60 °C ([Table 8](#t8-ijms-14-10626){ref-type="table"}). Efficiency of primer pairs is reported in [Table 1](#t1-ijms-14-10626){ref-type="table"}. Melting curves were obtained at the end of each run to confirm a single PCR product. All samples were run in triplicate. Non-template controls were included in each run to exclude contamination and nonspecific amplification. Expression levels of samples were normalised by using a normalisation factor calculated by the program geNorm. This normalisation factor was calculated based on RT-qPCR results for three selected reference genes, ACTB, TOP2B and TBP.

This allowed quantification of the target gene in one sample relative to that in another (the calibrator) using the "2^−ΔΔCt^ method" of calculating fold changes in gene expression \[[@b103-ijms-14-10626]\]. Correlation analysis between qRT-PCR and microarray was conducted.

5. Conclusions
==============

We have generated reliable mRNA transcriptomes of swine lung tissues from APP-infected and negative control pigs. We have identified a set of differentially expressed (DE) genes in our current case-control study, and a functional enrichment analysis indicated that these DE genes mainly related to "host immune response" and "host response". In addition, we also found that, in the APP-infected lung tissues, many proinflammatory-inflammatory cytokines were activated and involved in the regulation of the host defense response at the site of inflammation, while the cytokines involved in regulation of the host immune response were suppressed. The current study provides data that can be used in future studies to decipher the molecular mechanism of the systematic influences from porcine pleuropneumonia. Our findings will also help promote the further development of therapy for porcine pleuropneumonia.
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![(**A**) Normal lung from healthy swine; (**B**) Damaged lung after APP infection (Lung in TG showing swelling, bleeding and fibrinous exudate sticking to the lung surface; while no lesion in CG).](ijms-14-10626f1){#f1-ijms-14-10626}

![No lesions were observed in CG lung tissue (scale bar = 50 μm, 200×).](ijms-14-10626f2){#f2-ijms-14-10626}

![Alveolar cavities were filled with pink serum and red blood cells (**A**) (scale bar = 50 μm, 200×). and filled with serum, lymphocyte infiltration in the alveolar wall (**B**) (scale bar = 25 μm, 400×) in the lung of TG.](ijms-14-10626f3){#f3-ijms-14-10626}

![Hierarchical clustering analysis and clustering segmentation.](ijms-14-10626f4){#f4-ijms-14-10626}

![Three-dimensional map of principal component analysis (PCA) for mapping samples obtained from clustering segmentation.](ijms-14-10626f5){#f5-ijms-14-10626}

![The heat map shows the clustered genes in the leading edge subsets. In the heat map, expression values are represented as colors, where the range of colors (red, pink, light blue, dark blue) represents the range of expression values (high, moderate, low, lowest) in the CG. This pattern is reversed in the TG.](ijms-14-10626f6){#f6-ijms-14-10626}

![Validation of the microarray data by the real-time qRT-PCR analyses of ten representative genes. The x-axis represents the genes and the y-axis shows their relative expression levels (−ΔCt) values for quantitative real-time RT-PCR; Log (Sample signal, 10) for microarray. Three biological replicates were conducted for both assays. R represents the Pearson correlation coefficient. The significance of differences for gene expression between the CG and the TG was calculated using a two-tailed *T*-test.](ijms-14-10626f7){#f7-ijms-14-10626}

###### 

Eigenvalues and contribution ratio of principal component analysis (PCA) for differential expression genes.

  Principal component   Eigenvalues   Contribution ratio
  --------------------- ------------- --------------------
  1                     50.17         96.95%
  2                     1.339         2.59%
  3                     0.111         0.21%
  4                     0.088         0.17%
  5                     0.027         0.05%
  6                     0.013         0.02%

###### 

The significant gene ontology biological processes in pigs.

  Name             Description                                                Probe   Genes
  ---------------- ---------------------------------------------------------- ------- -------
  \[GO:0050896\]   response to stimulus                                       96      96
  \[GO:0051179\]   Localization                                               92      92
  \[GO:0006810\]   Transport                                                  88      88
  \[GO:0006807\]   nitrogen compound metabolic process                        84      84
  \[GO:0019222\]   regulation of metabolic process                            67      67
  \[GO:0002376\]   immune system process                                      56      56
  \[GO:0055114\]   oxidation reduction                                        53      53
  \[GO:0006955\]   immune response                                            53      53
  \[GO:0032501\]   multicellular organismal process                           52      52
  \[GO:0006950\]   response to stress                                         51      51
  \[GO:0009056\]   catabolic process                                          50      50
  \[GO:0032502\]   developmental process                                      38      38
  \[GO:0065008\]   regulation of biological quality                           35      35
  \[GO:0007275\]   multicellular organismal development                       35      35
  \[GO:0022610\]   biological adhesion                                        29      29
  \[GO:0048518\]   positive regulation of biological process                  28      28
  \[GO:0016043\]   cellular component organization                            27      27
  \[GO:0009605\]   response to external stimulus                              25      25
  \[GO:0048856\]   anatomical structure development                           22      22
  \[GO:0008219\]   cell death                                                 22      22
  \[GO:0048519\]   negative regulation of biological process                  21      21
  \[GO:0033036\]   macromolecule localization                                 21      21
  \[GO:0048523\]   negative regulation of cellular process                    19      19
  \[GO:0048522\]   positive regulation of cellular process                    19      19
  \[GO:0044281\]   small molecule metabolic process                           18      18
  \[GO:0048869\]   cellular developmental process                             17      17
  \[GO:0042221\]   response to chemical stimulus                              17      17
  \[GO:0006066\]   alcohol metabolic process                                  17      17
  \[GO:0006996\]   organelle organization                                     16      16
  \[GO:0051641\]   cellular localization                                      15      15
  \[GO:0019882\]   antigen processing and presentation                        15      15
  \[GO:0008104\]   protein localization                                       15      15
  \[GO:0048583\]   regulation of response to stimulus                         13      13
  \[GO:0042592\]   homeostatic process                                        12      12
  \[GO:0032879\]   regulation of localization                                 12      12
  \[GO:0007049\]   cell cycle                                                 12      12
  \[GO:0048584\]   positive regulation of response to stimulus                11      11
  \[GO:0009893\]   positive regulation of metabolic process                   11      11
  \[GO:0002682\]   regulation of immune system process                        11      11
  \[GO:0051716\]   cellular response to stimulus                              10      10
  \[GO:0019725\]   cellular homeostasis                                       10      10
  \[GO:0016192\]   vesicle-mediated transport                                 10      10
  \[GO:0009653\]   anatomical structure morphogenesis                         10      10
  \[GO:0002252\]   immune effector process                                    10      10
  \[GO:0051239\]   regulation of multicellular organismal process             9       9
  \[GO:0048731\]   system development                                         9       9
  \[GO:0065009\]   regulation of molecular function                           8       8
  \[GO:0051704\]   multi-organism process                                     8       8
  \[GO:0051128\]   regulation of cellular component organization              8       8
  \[GO:0050778\]   positive regulation of immune response                     8       8
  \[GO:0044085\]   cellular component biogenesis                              8       8
  \[GO:0007610\]   behavior                                                   8       8
  \[GO:0003008\]   system process                                             8       8
  \[GO:0051301\]   cell division                                              7       7
  \[GO:0030029\]   actin filament-based process                               7       7
  \[GO:0022607\]   cellular component assembly                                7       7
  \[GO:0009607\]   response to biotic stimulus                                7       7
  \[GO:0000003\]   reproduction                                               7       7
  \[GO:0055085\]   transmembrane transport                                    6       6
  \[GO:0051707\]   response to other organism                                 6       6
  \[GO:0051129\]   negative regulation of cellular component organization     6       6
  \[GO:0050878\]   regulation of body fluid levels                            6       6
  \[GO:0050793\]   regulation of developmental process                        6       6
  \[GO:0023052\]   signaling                                                  6       6
  \[GO:0022414\]   reproductive process                                       6       6
  \[GO:0016044\]   cellular membrane organization                             6       6
  \[GO:0048646\]   anatomical structure formation involved in morphogenesis   5       5
  \[GO:0040011\]   locomotion                                                 5       5
  \[GO:0019953\]   sexual reproduction                                        5       5
  \[GO:0019637\]   organophosphate metabolic process                          5       5
  \[GO:0010817\]   regulation of hormone levels                               5       5
  \[GO:0009892\]   negative regulation of metabolic process                   5       5
  \[GO:0060348\]   bone development                                           4       4
  \[GO:0044087\]   regulation of cellular component biogenesis                4       4
  \[GO:0043933\]   macromolecular complex subunit organization                4       4
  \[GO:0042330\]   taxis                                                      4       4
  \[GO:0040008\]   regulation of growth                                       4       4
  \[GO:0022402\]   cell cycle process                                         4       4
  \[GO:0070271\]   protein complex biogenesis                                 3       3
  \[GO:0048609\]   reproductive process in a multicellular organism           3       3
  \[GO:0046903\]   secretion                                                  3       3
  \[GO:0040012\]   regulation of locomotion                                   3       3
  \[GO:0034621\]   cellular macromolecular complex subunit organization       3       3
  \[GO:0019748\]   secondary metabolic process                                3       3
  \[GO:0010605\]   negative regulation of macromolecule metabolic process     3       3
  \[GO:0009719\]   response to endogenous stimulus                            3       3
  \[GO:0009628\]   response to abiotic stimulus                               3       3
  \[GO:0007017\]   microtubule-based process                                  3       3
  \[GO:0002520\]   immune system development                                  3       3

###### 

The significant gene ontology cellular components in pigs.

  Name             Description                                                                 Probe   Genes
  ---------------- --------------------------------------------------------------------------- ------- -------
  \[GO:0005886\]   plasma membrane                                                             98      98
  \[GO:0005634\]   nucleus                                                                     86      86
  \[GO:0032991\]   macromolecular complex                                                      86      86
  \[GO:0044422\]   organelle part                                                              84      84
  \[GO:0043234\]   protein complex                                                             62      62
  \[GO:0043228\]   non-membrane-bounded organelle                                              46      46
  \[GO:0044421\]   extracellular region part                                                   45      45
  \[GO:0044459\]   plasma membrane part                                                        44      44
  \[GO:0031090\]   organelle membrane                                                          41      41
  \[GO:0005739\]   mitochondrion                                                               37      37
  \[GO:0005783\]   endoplasmic reticulum                                                       35      35
  \[GO:0005794\]   Golgi apparatus                                                             33      33
  \[GO:0005615\]   extracellular space                                                         29      29
  \[GO:0012505\]   endomembrane system                                                         25      25
  \[GO:0044429\]   mitochondrial part                                                          23      23
  \[GO:0016023\]   cytoplasmic membrane-bounded vesicle                                        23      23
  \[GO:0005856\]   cytoskeleton                                                                23      23
  \[GO:0031974\]   membrane-enclosed lumen                                                     22      22
  \[GO:0031975\]   envelope                                                                    21      21
  \[GO:0005840\]   ribosome                                                                    19      19
  \[GO:0044428\]   nuclear part                                                                18      18
  \[GO:0005578\]   proteinaceous extracellular matrix                                          17      17
  \[GO:0044430\]   cytoskeletal part                                                           15      15
  \[GO:0071212\]   subsynaptic reticulum                                                       15      15
  \[GO:0005740\]   mitochondrial envelope                                                      15      15
  \[GO:0005829\]   cytosol                                                                     14      14
  \[GO:0031966\]   mitochondrial membrane                                                      14      14
  \[GO:0019898\]   extrinsic to membrane                                                       14      14
  \[GO:0042611\]   MHC protein complex                                                         13      13
  \[GO:0048770\]   pigment granule                                                             12      12
  \[GO:0044431\]   Golgi apparatus part                                                        12      12
  \[GO:0005773\]   vacuole                                                                     11      11
  \[GO:0005764\]   lysosome                                                                    10      10
  \[GO:0044432\]   endoplasmic reticulum part                                                  10      10
  \[GO:0005792\]   microsome                                                                   9       9
  \[GO:0009898\]   internal side of plasma membrane                                            9       9
  \[GO:0005743\]   mitochondrial inner membrane                                                9       9
  \[GO:0005887\]   integral to plasma membrane                                                 8       8
  \[GO:0005789\]   endoplasmic reticulum membrane                                              8       8
  \[GO:0005768\]   endosome                                                                    8       8
  \[GO:0005759\]   mitochondrial matrix                                                        8       8
  \[GO:0005654\]   nucleoplasm                                                                 8       8
  \[GO:0015630\]   microtubule cytoskeleton                                                    8       8
  \[GO:0030054\]   cell junction                                                               7       7
  \[GO:0031300\]   intrinsic to organelle membrane                                             7       7
  \[GO:0042613\]   MHC class II protein complex                                                7       7
  \[GO:0044451\]   nucleoplasm part                                                            7       7
  \[GO:0031301\]   integral to organelle membrane                                              6       6
  \[GO:0005635\]   nuclear envelope                                                            6       6
  \[GO:0042612\]   MHC class I protein complex                                                 6       6
  \[GO:0015629\]   actin cytoskeleton                                                          6       6
  \[GO:0016469\]   proton-transporting two-sector ATPase complex                               6       6
  \[GO:0031225\]   anchored to membrane                                                        5       5
  \[GO:0031968\]   organelle outer membrane                                                    5       5
  \[GO:0031965\]   nuclear membrane                                                            5       5
  \[GO:0043235\]   receptor complex                                                            5       5
  \[GO:0033279\]   ribosomal subunit                                                           5       5
  \[GO:0005819\]   spindle                                                                     4       4
  \[GO:0030173\]   integral to Golgi membrane                                                  4       4
  \[GO:0048471\]   perinuclear region of cytoplasm                                             4       4
  \[GO:0005911\]   cell-cell junction                                                          4       4
  \[GO:0043292\]   contractile fiber                                                           4       4
  \[GO:0000502\]   proteasome complex                                                          4       4
  \[GO:0030135\]   coated vesicle                                                              4       4
  \[GO:0016459\]   myosin complex                                                              4       4
  \[GO:0005874\]   microtubule                                                                 4       4
  \[GO:0042995\]   cell projection                                                             3       3
  \[GO:0045259\]   proton-transporting ATP synthase complex                                    3       3
  \[GO:0044420\]   extracellular matrix part                                                   3       3
  \[GO:0015935\]   small ribosomal subunit                                                     3       3
  \[GO:0005777\]   peroxisome                                                                  3       3
  \[GO:0034702\]   ion channel complex                                                         3       3
  \[GO:0005901\]   caveola                                                                     3       3
  \[GO:0045202\]   synapse                                                                     3       3
  \[GO:0031227\]   intrinsic to endoplasmic reticulum membrane                                 3       3
  \[GO:0016323\]   basolateral plasma membrane                                                 3       3
  \[GO:0005681\]   spliceosomal complex                                                        3       3
  \[GO:0030141\]   secretory granule                                                           3       3
  \[GO:0005667\]   transcription factor complex                                                3       3
  \[GO:0033176\]   proton-transporting V-type ATPase complex                                   3       3
  \[GO:0033177\]   proton-transporting two-sector ATPase complex, proton-transporting domain   3       3
  \[GO:0005730\]   nucleolus                                                                   3       3

###### 

The significant gene ontology molecular functions in pigs.

  Name             Description                                                                                                                                                                  Probe   Genes
  ---------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------- -------
  \[GO:0017076\]   purine nucleotide binding                                                                                                                                                    91      91
  \[GO:0003676\]   nucleic acid binding                                                                                                                                                         88      88
  \[GO:0032555\]   purine ribonucleotide binding                                                                                                                                                81      81
  \[GO:0004872\]   receptor activity                                                                                                                                                            75      75
  \[GO:0004690\]   cyclic nucleotide-dependent protein kinase activity                                                                                                                          68      68
  \[GO:0004691\]   cAMP-dependent protein kinase activity                                                                                                                                       67      67
  \[GO:0016491\]   oxidoreductase activity                                                                                                                                                      67      67
  \[GO:0008270\]   zinc ion binding                                                                                                                                                             64      64
  \[GO:0030554\]   adenyl nucleotide binding                                                                                                                                                    63      63
  \[GO:0005102\]   receptor binding                                                                                                                                                             57      57
  \[GO:0032559\]   adenyl ribonucleotide binding                                                                                                                                                53      53
  \[GO:0005215\]   transporter activity                                                                                                                                                         52      52
  \[GO:0008233\]   peptidase activity                                                                                                                                                           46      46
  \[GO:0070011\]   peptidase activity, acting on [l]{.smallcaps}-amino acid peptides                                                                                                            43      43
  \[GO:0003677\]   DNA binding                                                                                                                                                                  43      43
  \[GO:0004888\]   transmembrane receptor activity                                                                                                                                              40      40
  \[GO:0005509\]   calcium ion binding                                                                                                                                                          39      39
  \[GO:0022892\]   substrate-specific transporter activity                                                                                                                                      39      39
  \[GO:0004687\]   myosin light chain kinase activity                                                                                                                                           38      38
  \[GO:0030528\]   transcription regulator activity                                                                                                                                             37      37
  \[GO:0022857\]   transmembrane transporter activity                                                                                                                                           36      36
  \[GO:0022891\]   substrate-specific transmembrane transporter activity                                                                                                                        35      35
  \[GO:0030234\]   enzyme regulator activity                                                                                                                                                    35      35
  \[GO:0005506\]   iron ion binding                                                                                                                                                             33      33
  \[GO:0004175\]   endopeptidase activity                                                                                                                                                       33      33
  \[GO:0003700\]   transcription factor activity                                                                                                                                                32      32
  \[GO:0015075\]   ion transmembrane transporter activity                                                                                                                                       30      30
  \[GO:0019001\]   guanyl nucleotide binding                                                                                                                                                    28      28
  \[GO:0005198\]   structural molecule activity                                                                                                                                                 28      28
  \[GO:0004857\]   enzyme inhibitor activity                                                                                                                                                    26      26
  \[GO:0016788\]   hydrolase activity, acting on ester bonds                                                                                                                                    26      26
  \[GO:0008324\]   cation transmembrane transporter activity                                                                                                                                    25      25
  \[GO:0009055\]   electron carrier activity                                                                                                                                                    24      24
  \[GO:0004930\]   G-protein coupled receptor activity                                                                                                                                          24      24
  \[GO:0003723\]   RNA binding                                                                                                                                                                  23      23
  \[GO:0005126\]   cytokine receptor binding                                                                                                                                                    22      22
  \[GO:0016874\]   ligase activity                                                                                                                                                              22      22
  \[GO:0048037\]   cofactor binding                                                                                                                                                             20      20
  \[GO:0016817\]   hydrolase activity, acting on acid anhydrides                                                                                                                                19      19
  \[GO:0003735\]   structural constituent of ribosome                                                                                                                                           19      19
  \[GO:0005125\]   cytokine activity                                                                                                                                                            18      18
  \[GO:0030414\]   peptidase inhibitor activity                                                                                                                                                 18      18
  \[GO:0050662\]   coenzyme binding                                                                                                                                                             17      17
  \[GO:0016757\]   transferase activity, transferring glycosyl groups                                                                                                                           17      17
  \[GO:0030246\]   carbohydrate binding                                                                                                                                                         17      17
  \[GO:0008092\]   cytoskeletal protein binding                                                                                                                                                 16      16
  \[GO:0022890\]   inorganic cation transmembrane transporter activity                                                                                                                          16      16
  \[GO:0016746\]   transferase activity, transferring acyl groups                                                                                                                               16      16
  \[GO:0016879\]   ligase activity, forming carbon-nitrogen bonds                                                                                                                               16      16
  \[GO:0000287\]   magnesium ion binding                                                                                                                                                        15      15
  \[GO:0008237\]   metallopeptidase activity                                                                                                                                                    15      15
  \[GO:0016614\]   oxidoreductase activity, acting on CH--OH group of donors                                                                                                                    15      15
  \[GO:0022804\]   active transmembrane transporter activity                                                                                                                                    15      15
  \[GO:0019955\]   cytokine binding                                                                                                                                                             14      14
  \[GO:0017171\]   serine hydrolase activity                                                                                                                                                    14      14
  \[GO:0046906\]   tetrapyrrole binding                                                                                                                                                         14      14
  \[GO:0016616\]   oxidoreductase activity, acting on the CH--OH group of donors, NAD or NADP as acceptor                                                                                       14      14
  \[GO:0016747\]   transferase activity, transferring acyl groups other than amino-acyl groups                                                                                                  14      14
  \[GO:0008528\]   peptide receptor activity, G-protein coupled                                                                                                                                 14      14
  \[GO:0003779\]   actin binding                                                                                                                                                                14      14
  \[GO:0004252\]   serine-type endopeptidase activity                                                                                                                                           13      13
  \[GO:0016705\]   oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen                                                                        13      13
  \[GO:0004497\]   monooxygenase activity                                                                                                                                                       12      12
  \[GO:0042578\]   phosphoric ester hydrolase activity                                                                                                                                          12      12
  \[GO:0008234\]   cysteine-type peptidase activity                                                                                                                                             11      11
  \[GO:0046873\]   metal ion transmembrane transporter activity                                                                                                                                 11      11
  \[GO:0008289\]   lipid binding                                                                                                                                                                11      11
  \[GO:0016791\]   phosphatase activity                                                                                                                                                         11      11
  \[GO:0050660\]   FAD binding                                                                                                                                                                  10      10
  \[GO:0015078\]   hydrogen ion transmembrane transporter activity                                                                                                                              10      10
  \[GO:0016758\]   transferase activity, transferring hexosyl groups                                                                                                                            10      10
  \[GO:0004867\]   serine-type endopeptidase inhibitor activity                                                                                                                                 10      10
  \[GO:0004428\]   inositol or phosphatidylinositol kinase activity                                                                                                                             10      10
  \[GO:0016798\]   hydrolase activity, acting on glycosyl bonds                                                                                                                                 10      10
  \[GO:0005516\]   calmodulin binding                                                                                                                                                           9       9
  \[GO:0016810\]   hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds                                                                                                        9       9
  \[GO:0042623\]   ATPase activity, coupled                                                                                                                                                     9       9
  \[GO:0001871\]   pattern binding                                                                                                                                                              9       9
  \[GO:0016776\]   phosphotransferase activity, phosphate group as acceptor                                                                                                                     9       9
  \[GO:0005179\]   hormone activity                                                                                                                                                             9       9
  \[GO:0070851\]   growth factor receptor binding                                                                                                                                               9       9
  \[GO:0004197\]   cysteine-type endopeptidase activity                                                                                                                                         9       9
  \[GO:0005057\]   receptor signaling protein activity                                                                                                                                          9       9
  \[GO:0004950\]   chemokine receptor activity                                                                                                                                                  9       9
  \[GO:0004222\]   metalloendopeptidase activity                                                                                                                                                9       9
  \[GO:0043565\]   sequence-specific DNA binding                                                                                                                                                9       9
  \[GO:0005216\]   ion channel activity                                                                                                                                                         8       8
  \[GO:0016853\]   isomerase activity                                                                                                                                                           8       8
  \[GO:0000826\]   inositol pyrophosphate synthase activity                                                                                                                                     8       8
  \[GO:0019842\]   vitamin binding                                                                                                                                                              8       8
  \[GO:0005539\]   glycosaminoglycan binding                                                                                                                                                    8       8
  \[GO:0005529\]   sugar binding                                                                                                                                                                8       8
  \[GO:0005066\]   transmembrane receptor protein tyrosine kinase signaling protein activity                                                                                                    8       8
  \[GO:0020037\]   heme binding                                                                                                                                                                 8       8
  \[GO:0004356\]   glutamate-ammonia ligase activity                                                                                                                                            8       8
  \[GO:0005507\]   copper ion binding                                                                                                                                                           7       7
  \[GO:0016209\]   antioxidant activity                                                                                                                                                         7       7
  \[GO:0008238\]   exopeptidase activity                                                                                                                                                        7       7
  \[GO:0008009\]   chemokine activity                                                                                                                                                           7       7
  \[GO:0016860\]   intramolecular oxidoreductase activity                                                                                                                                       7       7
  \[GO:0004721\]   phosphoprotein phosphatase activity                                                                                                                                          7       7
  \[GO:0015291\]   secondary active transmembrane transporter activity                                                                                                                          7       7
  \[GO:0016563\]   transcription activator activity                                                                                                                                             6       6
  \[GO:0005244\]   voltage-gated ion channel activity                                                                                                                                           6       6
  \[GO:0008201\]   heparin binding                                                                                                                                                              6       6
  \[GO:0031420\]   alkali metal ion binding                                                                                                                                                     6       6
  \[GO:0046983\]   protein dimerization activity                                                                                                                                                6       6
  \[GO:0015082\]   di-, tri-valent inorganic cation transmembrane transporter activity                                                                                                          6       6
  \[GO:0004312\]   fatty-acid synthase activity                                                                                                                                                 6       6
  \[GO:0042802\]   identical protein binding                                                                                                                                                    6       6
  \[GO:0016684\]   oxidoreductase activity, acting on peroxide as acceptor                                                                                                                      6       6
  \[GO:0016829\]   lyase activity                                                                                                                                                               5       5
  \[GO:0008047\]   enzyme activator activity                                                                                                                                                    5       5
  \[GO:0003924\]   GTPase activity                                                                                                                                                              5       5
  \[GO:0004091\]   carboxylesterase activity                                                                                                                                                    5       5
  \[GO:0015399\]   primary active transmembrane transporter activity                                                                                                                            5       5
  \[GO:0005261\]   cation channel activity                                                                                                                                                      5       5
  \[GO:0019904\]   protein domain specific binding                                                                                                                                              5       5
  \[GO:0004694\]   eukaryotic translation initiation factor 2alpha kinase activity                                                                                                              5       5
  \[GO:0016627\]   oxidoreductase activity, acting on the CH--CH group of donors                                                                                                                5       5
  \[GO:0031406\]   carboxylic acid binding                                                                                                                                                      5       5
  \[GO:0042803\]   protein homodimerization activity                                                                                                                                            5       5
  \[GO:0004518\]   nuclease activity                                                                                                                                                            5       5
  \[GO:0019899\]   enzyme binding                                                                                                                                                               5       5
  \[GO:0003774\]   motor activity                                                                                                                                                               5       5
  \[GO:0008430\]   selenium binding                                                                                                                                                             5       5
  \[GO:0004725\]   protein tyrosine phosphatase activity                                                                                                                                        5       5
  \[GO:0015293\]   symporter activity                                                                                                                                                           5       5
  \[GO:0004713\]   protein tyrosine kinase activity                                                                                                                                             5       5
  \[GO:0046915\]   transition metal ion transmembrane transporter activity                                                                                                                      4       4
  \[GO:0008135\]   translation factor activity, nucleic acid binding                                                                                                                            4       4
  \[GO:0008134\]   transcription factor binding                                                                                                                                                 4       4
  \[GO:0010857\]   calcium-dependent protein kinase activity                                                                                                                                    4       4
  \[GO:0050661\]   NADP or NADPH binding                                                                                                                                                        4       4
  \[GO:0060589\]   nucleoside-triphosphatase regulator activity                                                                                                                                 4       4
  \[GO:0008373\]   sialyltransferase activity                                                                                                                                                   4       4
  \[GO:0004896\]   cytokine receptor activity                                                                                                                                                   4       4
  \[GO:0008083\]   growth factor activity                                                                                                                                                       4       4
  \[GO:0016709\]   oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen   4       4
  \[GO:0004576\]   oligosaccharyl transferase activity                                                                                                                                          4       4
  \[GO:0008509\]   anion transmembrane transporter activity                                                                                                                                     4       4
  \[GO:0051540\]   metal cluster binding                                                                                                                                                        4       4
  \[GO:0004177\]   aminopeptidase activity                                                                                                                                                      4       4
  \[GO:0016765\]   transferase activity, transferring alkyl or aryl (other than methyl) groups                                                                                                  4       4
  \[GO:0015929\]   hexosaminidase activity                                                                                                                                                      4       4
  \[GO:0016741\]   transferase activity, transferring one-carbon groups                                                                                                                         4       4
  \[GO:0004129\]   cytochrome-c oxidase activity                                                                                                                                                4       4
  \[GO:0004521\]   endoribonuclease activity                                                                                                                                                    4       4
  \[GO:0051287\]   NAD or NADH binding                                                                                                                                                          3       3
  \[GO:0005385\]   zinc ion transmembrane transporter activity                                                                                                                                  3       3
  \[GO:0004774\]   succinate-CoA ligase activity                                                                                                                                                3       3
  \[GO:0004090\]   carbonyl reductase (NADPH) activity                                                                                                                                          3       3
  \[GO:0005249\]   voltage-gated potassium channel activity                                                                                                                                     3       3
  \[GO:0008757\]   S-adenosylmethionine-dependent methyltransferase activity                                                                                                                    3       3
  \[GO:0005160\]   transforming growth factor beta receptor binding                                                                                                                             3       3
  \[GO:0008235\]   metalloexopeptidase activity                                                                                                                                                 3       3
  \[GO:0005275\]   amine transmembrane transporter activity                                                                                                                                     3       3
  \[GO:0019840\]   isoprenoid binding                                                                                                                                                           3       3
  \[GO:0019838\]   growth factor binding                                                                                                                                                        3       3
  \[GO:0005128\]   erythropoietin receptor binding                                                                                                                                              3       3
  \[GO:0016801\]   hydrolase activity, acting on ether bonds                                                                                                                                    3       3
  \[GO:0016701\]   oxidoreductase activity, acting on single donors with incorporation of molecular oxygen                                                                                      3       3
  \[GO:0003712\]   transcription cofactor activity                                                                                                                                              3       3
  \[GO:0015144\]   carbohydrate transmembrane transporter activity                                                                                                                              3       3
  \[GO:0003995\]   acyl-CoA dehydrogenase activity                                                                                                                                              3       3
  \[GO:0004869\]   cysteine-type endopeptidase inhibitor activity                                                                                                                               3       3
  \[GO:0031402\]   sodium ion binding                                                                                                                                                           3       3
  \[GO:0019888\]   protein phosphatase regulator activity                                                                                                                                       3       3
  \[GO:0016651\]   oxidoreductase activity, acting on NADH or NADPH                                                                                                                             3       3
  \[GO:0004180\]   carboxypeptidase activity                                                                                                                                                    3       3
  \[GO:0030695\]   GTPase regulator activity                                                                                                                                                    3       3
  \[GO:0010181\]   FMN binding                                                                                                                                                                  3       3
  \[GO:0003743\]   translation initiation factor activity                                                                                                                                       3       3
  \[GO:0016861\]   intramolecular oxidoreductase activity, interconverting aldoses and ketoses                                                                                                  3       3
  \[GO:0004522\]   pancreatic ribonuclease activity                                                                                                                                             3       3
  \[GO:0015294\]   solute:cation symporter activity                                                                                                                                             3       3
  \[GO:0016790\]   thiolester hydrolase activity                                                                                                                                                3       3
  \[GO:0008026\]   ATP-dependent helicase activity                                                                                                                                              3       3
  \[GO:0030145\]   manganese ion binding                                                                                                                                                        3       3
  \[GO:0008417\]   fucosyltransferase activity                                                                                                                                                  3       3
  \[GO:0008194\]   UDP-glycosyltransferase activity                                                                                                                                             3       3
  \[GO:0008199\]   ferric iron binding                                                                                                                                                          3       3

###### 

Significant GO terms related to the immune responses caused by infection with APP.

  NO   GO term      Biological process                            Number P~ermineJ~   
  ---- ------------ --------------------------------------------- ------------------- ---
  1    GO:0050896   response to stimulus                          96                  0
  2    GO:0051179   Localization                                  92                  0
  3    GO:0002376   immune system process                         56                  0
  4    GO:0006955   immune response                               53                  0
  5    GO:0055114   oxidation reduction                           53                  0
  1    GO:0050896   response to stimulus                          96                  0
  6    GO:0006950   response to stress                            51                  0
  7    GO:0022610   biological adhesion                           29                  0
  8    GO:0009605   response to external stimulus                 25                  0
  9    GO:0008219   cell death                                    22                  0
  10   GO:0033036   macromolecule localization                    21                  0
  11   GO:0042221   response to chemical stimulus                 17                  0
  12   GO:0019882   antigen processing and presentation           15                  0
  13   GO:0048583   regulation of response to stimulus            13                  0
  14   GO:0032879   regulation of localization                    12                  0
  15   GO:0042592   homeostatic process                           12                  0
  16   GO:0048584   positive regulation of response to stimulus   11                  0
  17   GO:0002682   regulation of immune system process           11                  0
  18   GO:0051716   cellular response to stimulus                 10                  0
  19   GO:0002252   immune effector process                       10                  0
  20   GO:0050778   positive regulation of immune response        8                   0
  21   GO:0009607   response to biotic stimulus                   7                   0
  22   GO:0023052   signaling                                     6                   0
  23   GO:0040011   locomotion                                    5                   0
  24   GO:0042330   taxis                                         4                   0
  25   GO:0002520   immune system development                     3                   0
  26   GO:0009628   response to abiotic stimulus                  3                   0
  27   GO:0009719   response to endogenous stimulus               3                   0

###### 

Gene sets enriched in phenotype treatment group (TG).

  NO.   Pathway                                                  Size   ES      NES     NOM *p*-val   FDR *q*-val   FWER *p*-val   Rank at max   Leading edge
  ----- -------------------------------------------------------- ------ ------- ------- ------------- ------------- -------------- ------------- ----------------------------------------
  1     ssc04664: Fc epsilon RI signaling pathway                13     −0.74   −1.83   0.001         0.084         0.064          89            Tags = 77%, list = 17%, signal = 91%
  2     ssc04930: Type II diabetes mellitus                      5      −0.82   −1.62   0.017         0.715         0.685          42            Tags = 60%, list = 8%, signal = 65%
  3     ssc04914: Progesterone-mediated oocyte maturation        12     −0.66   −1.61   0.012         0.508         0.701          56            Tags = 42%, list = 11%, signal = 46%
  4     ssc00140: Steroid hormone biosynthesis                   4      −0.85   −1.58   0.012         0.529         0.814          44            Tags = 75%, list = 9%, signal = 81%
  5     ssc04621: NOD-like receptor signaling pathway            13     −0.62   −1.56   0.019         0.49          0.861          49            tags = 46%, list = 10%, signal = 50%
  6     ssc05221: Acute myeloid leukemia                         11     −0.63   −1.54   0.034         0.478         0.901          133           tags = 73%, list = 26%, signal = 96%
  7     ssc05218: Melanoma                                       10     −0.64   −1.51   0.049         0.562         0.955          100           tags = 50%, list = 19%, signal = 61%
  8     ssc03040: Spliceosome                                    9      −0.67   −1.5    0.039         0.524         0.961          101           tags = 44%, list = 20%, signal = 54%
  9     ssc04640: Hematopoietic cell lineage                     19     −0.53   −1.48   0.055         0.55          0.982          120           tags = 58%, list = 23%, signal = 73%
  10    ssc04210: Apoptosis                                      10     −0.61   −1.48   0.066         0.504         0.984          158           tags = 70%, list = 31%, signal = 99%
  11    Ssc05214: Glioma                                         11     −0.61   −1.47   0.052         0.467         0.985          100           tags = 45%, list = 19%, signal = 55%
  12    ssc04012: ErbB signaling pathway                         13     −0.56   −1.45   0.076         0.539         0.999          102           tags = 38%, list = 20%, signal = 47%
  13    ssc05020: Prion diseases                                 8      −0.64   −1.44   0.07          0.533         1              65            tags = 50%, list = 13%, signal = 56%
  14    ssc04666: Fc gamma R-mediated phagocytosis               12     −0.56   −1.4    0.098         0.641         1              135           tags = 67%, list = 26%, signal = 88%
  15    ssc04650: Natural killer cell mediated cytotoxicity      19     −0.52   −1.4    0.087         0.605         1              89            tags = 42%, list = 17%, signal = 49%
  16    ssc00650: Butanoate metabolism                           5      −0.72   −1.39   0.088         0.581         1              6             tags = 20%, list = 1%, signal = 20%
  17    ssc00410: Beta-Alanine metabolism                        5      −0.71   −1.38   0.076         0.603         1              6             tags = 20%, list = 1%, signal = 20%
  18    ssc04660: T cell receptor signaling pathway              18     −0.49   −1.35   0.112         0.689         1              122           tags = 56%, list = 24%, signal = 70%
  19    ssc04370: VEGF signaling pathway                         8      −0.61   −1.35   0.152         0.664         1              122           tags = 63%, list = 24%, signal = 81%
  20    ssc05219: Bladder cancer                                 10     −0.56   −1.34   0.132         0.648         1              147           tags = 60%, list = 29%, signal = 82%
  21    ssc04920: Adipocytokine signaling pathway                12     −0.53   −1.34   0.146         0.634         1              78            tags = 42%, list = 15%, signal = 48%
  22    ssc04114: Oocyte meiosis                                 12     −0.54   −1.34   0.132         0.608         1              56            tags = 25%, list = 11%, signal = 27%
  23    ssc00750: Vitamin B6 metabolism                          2      −0.86   −1.33   0.09          0.6           1              72            tags = 100%, list = 14%, signal = 116%
  24    ssc00260: Glycine, serine and threonine metabolism       4      −0.71   −1.32   0.131         0.597         1              128           tags = 75%, list = 25%, signal = 99%
  25    ssc04960: Aldosterone-regulated sodium reabsorption      5      −0.69   −1.32   0.139         0.579         1              106           tags = 60%, list = 21%, signal = 75%
  26    ssc00910: Nitrogen metabolism                            3      −0.76   −1.29   0.164         0.646         1              91            tags = 67%, list = 18%, signal = 81%
  27    ssc05220: Chronic myeloid leukemia                       14     −0.5    −1.27   0.206         0.69          1              172           tags = 57%, list = 34%, signal = 84%
  28    ssc04115: P53 signaling pathway                          12     −0.51   −1.27   0.197         0.687         1              156           tags = 75%, list = 30%, signal = 105%
  29    ssc04630: Jak-STAT signaling pathway                     19     −0.44   −1.22   0.234         0.813         1              105           tags = 42%, list = 20%, signal = 51%
  30    ssc00640: Propanoate metabolism                          9      −0.53   −1.22   0.23          0.798         1              61            tags = 22%, list = 12%, signal = 25%
  31    ssc05213: Endometrial cancer                             10     −0.51   −1.21   0.248         0.787         1              133           tags = 50%, list = 26%, signal = 66%
  32    ssc00591: Linoleic acid metabolism                       4      −0.66   −1.19   0.27          0.829         1              44            tags = 75%, list = 9%, signal = 81%
  33    ssc05215: Prostate cancer                                17     −0.44   −1.19   0.243         0.811         1              115           tags = 35%, list = 22%, signal = 44%
  34    ssc00280: Valine, leucine and isoleucine degradation     11     −0.49   −1.18   0.269         0.826         1              157           tags = 45%, list = 31%, signal = 64%
  35    ssc00620: Pyruvate metabolism                            7      −0.54   −1.17   0.285         0.818         1              239           tags = 100%, list = 47%, signal = 185%
  36    ssc00010: Glycolysis/Gluconeogenesis                     12     −0.47   −1.17   0.26          0.796         1              243           tags = 83%, list = 47%, signal = 155%
  37    ssc04150: MTOR signaling pathway                         7      −0.56   −1.17   0.291         0.78          1              42            tags = 29%, list = 8%, signal = 31%
  38    ssc00250: Alanine, aspartate and glutamate metabolism    5      −0.6    −1.16   0.302         0.79          1              6             tags = 20%, list = 1%, signal = 20%
  39    ssc00511: Other glycan degradation                       4      −0.63   −1.16   0.312         0.772         1              195           tags = 100%, list = 38%, signal = 160%
  40    ssc05212: Pancreatic cancer                              13     −0.45   −1.16   0.304         0.754         1              172           tags = 54%, list = 34%, signal = 79%
  41    ssc00604: Glycosphingolipid biosynthesis                 4      −0.63   −1.15   0.299         0.755         1              195           tags = 100%, list = 38%, signal = 160%
  42    ssc00052: Galactose metabolism                           3      −0.66   −1.12   0.338         0.835         1              52            tags = 33%, list = 10%, signal = 37%
  43    ssc00520: Amino sugar and nucleotide sugar metabolism    6      −0.54   −1.11   0.353         0.831         1              116           tags = 50%, list = 23%, signal = 64%
  44    ssc04070: Phosphatidylinositol signaling system          6      −0.55   −1.11   0.358         0.813         1              100           tags = 67%, list = 19%, signal = 82%
  45    ssc04662: B cell receptor signaling pathway              12     −0.45   −1.11   0.336         0.798         1              120           tags = 58%, list = 23%, signal = 74%
  46    ssc00500: Starch and sucrose metabolism                  4      −0.6    −1.1    0.37          0.809         1              57            tags = 50%, list = 11%, signal = 56%
  47    ssc05014: Amyotrophic lateral sclerosis (ALS)            5      −0.57   −1.09   0.404         0.812         1              49            tags = 40%, list = 10%, signal = 44%
  48    ssc00310: Lysine degradation                             4      −0.59   −1.09   0.381         0.795         1              149           tags = 75%, list = 29%, signal = 105%
  49    ssc04144: Endocytosis                                    18     −0.41   −1.08   0.384         0.814         1              26            tags = 17%, list = 5%, signal = 17%
  50    ssc00533: Keratan sulfate biosynthesis                   2      −0.69   −1.07   0.389         0.801         1              162           tags = 100%, list = 32%, signal = 146%
  51    ssc04623: Cytosolic DNA-sensing pathway                  8      −0.47   −1.07   0.4           0.791         1              30            tags = 25%, list = 6%, signal = 26%
  52    ssc00340: Histidine metabolism                           5      −0.55   −1.06   0.397         0.806         1              149           tags = 60%, list = 29%, signal = 84%
  53    ssc00980: Metabolism of xenobiotics by cytochrome P450   9      −0.45   −1.04   0.442         0.835         1              44            tags = 33%, list = 9%, signal = 36%
  54    ssc00270: Cysteine and methionine metabolism             5      −0.53   −1.04   0.478         0.824         1              245           tags = 100%, list = 48%, signal = 190%
  55    ssc04330: Notch signaling pathway                        6      −0.5    −1.03   0.473         0.833         1              4             tags = 17%, list = 1%, signal = 17%
  56    ssc00330: Arginine and proline metabolism                10     −0.43   −1.03   0.447         0.824         1              174           tags = 50%, list = 34%, signal = 74%
  57    ssc05223: Non-small cell lung cancer                     7      −0.47   −1.01   0.487         0.844         1              89            tags = 43%, list = 17%, signal = 51%
  58    ssc04720: Long-term potentiation                         8      −0.46   −1.01   0.48          0.84          1              89            tags = 25%, list = 17%, signal = 30%
  59    ssc04110: Cell cycle                                     19     −0.36   −1      0.472         0.832         1              220           tags = 58%, list = 43%, signal = 98%
  60    ssc04730: Long-term depression                           13     −0.39   −1      0.464         0.822         1              34            tags = 15%, list = 7%, signal = 16%
  61    ssc05211: Renal cell carcinoma                           13     −0.4    −1      0.467         0.812         1              193           tags = 62%, list = 38%, signal = 96%
  62    ssc04912: GnRH signaling pathway                         13     −0.38   −0.98   0.507         0.842         1              122           tags = 31%, list = 24%, signal = 39%
  63    ssc00983: Drug metabolism                                5      −0.5    −0.97   0.515         0.838         1              44            tags = 60%, list = 9%, signal = 65%
  64    ssc00450: Selenoamino acid metabolism                    3      −0.58   −0.97   0.547         0.84          1              176           tags = 67%, list = 34%, signal = 101%
  65    ssc00071: Fatty acid metabolism                          8      −0.43   −0.95   0.556         0.856         1              244           tags = 75%, list = 48%, signal = 141%
  66    ssc00020: Citrate cycle (TCA cycle)                      9      −0.41   −0.95   0.533         0.845         1              309           tags = 100%, list = 60%, signal = 247%
  67    ssc03018: RNA degradation                                2      −0.6    −0.93   0.583         0.866         1              206           tags = 100%, list = 40%, signal = 166%
  68    ssc00603: Glycosphingolipid biosynthesis                 6      −0.44   −0.93   0.58          0.866         1              195           tags = 83%, list = 38%, signal = 133%
  69    ssc00053: Ascorbate and aldarate metabolism              3      −0.54   −0.92   0.599         0.86          1              239           tags = 100%, list = 47%, signal = 186%
  70    ssc04020: Calcium signaling pathway                      20     −0.33   −0.92   0.578         0.85          1              29            tags = 10%, list = 6%, signal = 10%
  71    ssc00510: *N*-Glycan biosynthesis                        8      −0.41   −0.91   0.607         0.863         1              306           tags = 100%, list = 60%, signal = 244%
  72    ssc00903: Limonene and pinene degradation                3      −0.54   −0.91   0.631         0.851         1              239           tags = 100%, list = 47%, signal = 186%
  73    ssc03320: PPAR signaling pathway                         13     −0.36   −0.91   0.598         0.843         1              78            tags = 31%, list = 15%, signal = 35%
  74    ssc04142: Lysosome                                       16     −0.34   −0.89   0.623         0.867         1              195           tags = 75%, list = 38%, signal = 117%
  75    ssc05210: Colorectal cancer                              13     −0.35   −0.89   0.599         0.857         1              42            tags = 15%, list = 8%, signal = 16%
  76    ssc04622: RIG-I-like receptor signaling pathway          12     −0.35   −0.87   0.626         0.867         1              49            tags = 25%, list = 10%, signal = 27%
  77    ssc04320: Dorso-ventral axis formation                   2      −0.57   −0.87   0.674         0.86          1              34            tags = 50%, list = 7%, signal = 53%
  78    ssc04130: SNARE interactions in vesicular transport      2      −0.57   −0.87   0.676         0.857         1              123           tags = 50%, list = 24%, signal = 66%
  79    ssc00230: Purine metabolism                              6      −0.42   −0.85   0.68          0.869         1              21            tags = 17%, list = 4%, signal = 17%
  80    ssc00380: Tryptophan metabolism                          4      −0.46   −0.85   0.699         0.865         1              239           tags = 75%, list = 47%, signal = 139%
  81    ssc04910:Insulin signaling pathway                       16     −0.32   −0.84   0.688         0.859         1              104           tags = 25%, list = 20%, signal = 30%
  82    ssc00190: Oxidative phosphorylation                      17     −0.31   −0.84   0.666         0.85          1              317           tags = 94%, list = 62%, signal = 238%
  83    ssc00051: Fructose and mannose metabolism                4      −0.46   −0.84   0.697         0.848         1              69            tags = 25%, list = 13%, signal = 29%
  84    ssc04614: Renin-angiotensin system                       3      −0.5    −0.84   0.715         0.839         1              143           tags = 33%, list = 28%, signal = 46%
  85    ssc00860: Porphyrin and chlorophyll metabolism           3      −0.49   −0.83   0.709         0.836         1              238           tags = 67%, list = 46%, signal = 124%
  86    ssc00350: Tyrosine metabolism                            5      −0.43   −0.83   0.692         0.833         1              263           tags = 80%, list = 51%, signal = 163%
  87    ssc00561: Glycerolipid metabolism                        6      −0.38   −0.79   0.733         0.87          1              239           tags = 83%, list = 47%, signal = 154%
  88    ssc00030: Pentose phosphate pathway                      5      −0.41   −0.79   0.744         0.868         1              57            tags = 20%, list = 11%, signal = 22%
  89    ssc04540: Gap junction                                   11     −0.32   −0.77   0.764         0.884         1              134           tags = 27%, list = 26%, signal = 36%
  90    ssc04916: Melanogenesis                                  14     −0.29   −0.75   0.787         0.892         1              145           tags = 29%, list = 28%, signal = 39%
  91    ssc00562: Inositol phosphate metabolism                  7      −0.35   −0.75   0.775         0.884         1              100           tags = 43%, list = 19%, signal = 53%
  92    ssc03050 Proteasome:                                     4      −0.4    −0.74   0.814         0.887         1              97            tags = 25%, list = 19%, signal = 31%
  93    ssc00600: Sphingolipid metabolism                        5      −0.36   −0.71   0.821         0.919         1              107           tags = 40%, list = 21%, signal = 50%
  94    ssc00630: Glyoxylate and dicarboxylate metabolism        2      −0.46   −0.7    0.907         0.916         1              142           tags = 50%, list = 28%, signal = 69%
  95    ssc04512: ECM-receptor interaction                       11     −0.29   −0.69   0.853         0.916         1              8             tags = 9%, list = 2%, signal = 9%
  96    ssc00531: Glycosaminoglycan degradation                  4      −0.35   −0.65   0.899         0.946         1              240           tags = 75%, list = 47%, signal = 140%
  97    ssc05216: Thyroid cancer                                 8      −0.29   −0.63   0.904         0.948         1              133           tags = 38%, list = 26%, signal = 50%
  98    ssc04520: Adherens junction                              10     −0.26   −0.61   0.902         0.957         1              170           tags = 40%, list = 33%, signal = 59%
  99    ssc00564: Glycerophospholipid metabolism                 5      −0.3    −0.58   0.94          0.969         1              219           tags = 60%, list = 43%, signal = 104%
  100   ssc00360: Phenylalanine metabolism                       5      −0.26   −0.51   0.972         0.992         1              219           tags = 60%, list = 43%, signal = 104%
  101   ssc04270: Vascular smooth muscle contraction             14     −0.18   −0.46   0.988         0.998         1              34            tags = 7%, list = 7%, signal = 7%
  102   ssc04350: TGF-beta signaling pathway                     14     −0.18   −0.45   0.982         0.99          1              172           tags = 36%, list = 34%, signal = 52%

###### 

Gene sets enriched in phenotype control group (CG).

  No.   Pathway                                                            Size   ES     NES    NOM *p*-val   FDR *q*-val   FWER *p*-val   Rank at Max   Leading edge
  ----- ------------------------------------------------------------------ ------ ------ ------ ------------- ------------- -------------- ------------- ----------------------------------------
  1     ssc05320: Autoimmune thyroid disease                               15     0.64   1.97   0.003         0.034         0.058          139           tags = 87%, list = 27%, signal = 115%
  2     ssc04940: Type I diabetes mellitus                                 16     0.59   1.86   0.003         0.053         0.165          139           tags = 88%, list = 27%, signal = 116%
  3     ssc05330: Allograft rejection                                      17     0.54   1.72   0.015         0.116         0.458          139           tags = 82%, list = 27%, signal = 109%
  4     Ssc04530: Tight junction                                           17     0.52   1.67   0.013         0.141         0.628          2             tags = 12%, list = 0%, signal = 11%
  5     ssc04260: Cardiac muscle contraction                               13     0.55   1.65   0.03          0.132         0.683          107           tags = 46%, list = 21%, signal = 57%
  6     ssc05412: Arrhythmogenic right ventricular cardiomyopathy          12     0.56   1.57   0.051         0.196         0.853          155           tags = 75%, list = 30%, signal = 105%
  7     ssc02010: ABC transporters                                         2      0.83   1.34   0.136         0.6           0.998          89            tags = 100%, list = 17%, signal = 121%
  8     ssc05340: Primary immunodeficiency                                 7      0.54   1.3    0.179         0.619         0.999          61            tags = 43%, list = 12%, signal = 48%
  9     ssc05217: Basal cell carcinoma                                     5      0.56   1.25   0.241         0.668         1              114           tags = 60%, list = 22%, signal = 76%
  10    ssc04740: Olfactory transduction                                   3      0.67   1.22   0.259         0.664         1              172           Tags = 100%, list = 34%, signal = 150%
  11    ssc04120: Ubiquitin mediated proteolysis                           8      0.47   1.18   0.271         0.683         1              32            Tags = 25%, list = 6%, signal = 26%
  12    ssc03010: Ribosome                                                 17     0.37   1.17   0.257         0.657         1              328           Tags = 100%, list = 64%, signal = 268%
  13    ssc01040: Biosynthesis of unsaturated fatty acids                  2      0.73   1.15   0.336         0.634         1              11            Tags = 50%, list = 2%, signal = 51%
  14    ssc05012: Parkinson's disease                                      17     0.35   1.13   0.302         0.633         1              337           Tags = 100%, list = 66%, signal = 282%
  15    ssc05332: Graft-versus-host disease                                15     0.36   1.1    0.367         0.646         1              139           Tags = 80%, list = 27%, signal = 107%
  16    ssc00590: Arachidonic acid metabolism                              11     0.39   1.08   0.352         0.634         1              55            Tags = 36%, list = 11%, signal = 40%
  17    ssc04360: Axon guidance                                            12     0.36   1.05   0.393         0.653         1              56            Tags = 33%, list = 11%, signal = 37%
  18    ssc04310: Wnt signaling pathway                                    14     0.35   1.03   0.462         0.66          1              132           Tags = 43%, list = 26%, signal = 56%
  19    ssc04340: Hedgehog signaling pathway                               3      0.55   1      0.479         0.671         1              114           Tags = 67%, list = 22%, signal = 85%
  20    ssc00982: Drug metabolism                                          12     0.35   0.99   0.455         0.651         1              40            Tags = 25%, list = 8%, signal = 26%
  21    ssc04080: Neuroactive ligand-receptor interaction                  17     0.29   0.94   0.525         0.706         1              43            tags = 29%, list = 8%, signal = 31%
  22    ssc00830: Retinol metabolism                                       7      0.39   0.94   0.524         0.682         1              16            Tags = 29%, list = 3%, signal = 29%
  23    ssc00565: Ether lipid metabolism                                   4      0.43   0.84   0.686         0.811         1              295           Tags = 100%, list = 58%, signal = 233%
  24    ssc05222: Small cell lung cancer                                   14     0.26   0.79   0.718         0.848         1              51            Tags = 21%, list = 10%, signal = 23%
  25    ssc00480: Glutathione metabolism                                   6      0.34   0.78   0.746         0.832         1              339           Tags = 100%, list = 66%, signal = 291%
  26    ssc05310: Asthma                                                   11     0.27   0.77   0.741         0.806         1              139           Tags = 73%, list = 27%, signal = 98%
  27    ssc00563: Glycosylphosphatidylinositol (GPI)-anchor biosynthesis   2      0.49   0.77   0.769         0.776         1              263           Tags = 100%, list = 51%, signal = 204%
  28    ssc00601: Glycosphingolipid biosynthesis                           4      0.33   0.68   0.846         0.857         1              164           Tags = 75%, list = 32%, signal = 109%

###### 

Information on the primers used for qRT-PCR.

  Confirmation objects        Gene symbol               Primer sequence (5′→3′)   Amplicon length (bp)   Ta (°C)        GenBank No.
  --------------------------- ------------------------- ------------------------- ---------------------- -------------- -------------
  *Reference gene*            *ACTB*                    TCTGGCACCACACCTTCT        114                    60             DQ178122
  TGATCTGGGTCATCTTCTCAC                                                                                                 
                                                                                                                        
  *TBP*                       GATGGACGTTCGGTTTAGG       124                       60                     DQ178129       
  AGCAGCACAGTACGAGCAA                                                                                                   
                                                                                                                        
  *TOP2B*                     AACTGGATGATGCTAATGATGCT   137                       60                     AF222921       
  TGGAAAAACTCCGTATCTGTCTC                                                                                               
                                                                                                                        
  *Up gene*                   *RETN*                    AGTGCGCTGGCATAGACTGG      197                    60             NM_213783
  CATCCTCTTCTCAAGGTTTATTTCC                                                                                             
                                                                                                                        
  *ADAM17*                    TTGAGGAAGGGGAAGCC         158                       56                     NM_001099926   
  ACGGAGCCCACGATGTT                                                                                                     
                                                                                                                        
  *GPNMB*                     GAGACCCAGCCTTCCTT         130                       51.2                   NM_001098584   
  TTGCTTTCTATCGCTTTGTA                                                                                                  
                                                                                                                        
  *CHRM1*                     CGCTGGTCAAGGAGAAGAA       185                       56                     NM_214034      
  GCACATGGGGTTGATGGT                                                                                                    
                                                                                                                        
  *ALDH2*                     AAACTGCTCTGCGGTGGA        181                       56                     NM_001044611   
  CGTACTTGGAATTGTTGGCTC                                                                                                 
                                                                                                                        
  *IL6*                       GTCGAGGCTGTGCAGATTAG      101                       56                     NM_214399      
  GCATTTGTGGTGGGGTTAG                                                                                                   
                                                                                                                        
  *Down gene*                 *KLRK1*                   TGATGTGATAAACCGTGGTG      107                    56             NM_213813
  TGGATCGGGCAAGGAAA                                                                                                     
                                                                                                                        
  *DUOX2*                     CCCTTCTTCAACTCCCTG        158                       51.2                   NM_213999      
  CAAAAGTTCTCATAGTGGTGC                                                                                                 
                                                                                                                        
  *OAS2*                      GACACGGCTGAAGGTTT         291                       51.2                   NM_001031796   
  TGGCACGTCCCAAGACT                                                                                                     
                                                                                                                        
  *KCNAB1*                    AAGGGAGAAAACAGCAAAAC      176                       56                     NM_001105294   
  AACCTGAATGGCACCGA                                                                                                     
